What is Janux Therapeutics's accounts receivable?

Janux Therapeutics (JANX) reported accounts receivable of $35M in Q1 2026.

What is the long-term trend for Janux Therapeutics's accounts receivable?

Over 2 years (2021 to 2023), Janux Therapeutics's accounts receivable has grown at a -100.0% compound annual growth rate (CAGR), from -$7.25M to $0.

What does accounts receivable mean?

Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.

Janux Therapeutics JANX Accounts Receivable

Accounts Receivable at other companies

Johnson & JohnsonJNJ

$17.72B+10.6%

AmgenAMGN

$9.14B+12.4%

Regeneron PharmaceuticalsREGN

$5.73B+3.1%

XencorXNCR

$12M-68.2%

AbbVieABBV

$12.48B0.0%

CRISPR TherapeuticsCRSP

$0—

Other financials

Income statement

See full

Revenue$3.7M—

Operating income-$34.2M+2.0%

Net income-$24.4M-3.6%

EPS (diluted)-$0.39-2.6%

Balance sheet

See full

Cash & equivalents$51.8M-29.7%

Total debt$21.6M-4.6%

Total equity$941.5M-7.0%

Total assets$1.0B-2.1%

Cash flow

See full

Operating cash flow-$12.3M+27.5%

CapEx$273.0K-26.4%

Free cash flow-$12.6M+27.5%

Valuation

See full

Market cap$892.81M-36.1%

Enterprise value$862.55M-35.9%

P/S65×-84.6×

Profitability

See full

Operating margin-1,143.1%-65.1pp

Net margin-833.6%+0.9pp

FCF margin-571.6%+98.3pp

Returns & leverage

See full

Return on equity-11.7%+4.1pp

Debt / equity0×0.0×

Current ratio17×-41.5×

Where this comes from

Reported directly by Janux Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ReceivablesNetCurrent.

The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Janux Therapeutics's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Janux Therapeutics's accounts receivable?: Janux Therapeutics (JANX) reported accounts receivable of $35M in Q1 2026.
What is the long-term trend for Janux Therapeutics's accounts receivable?: Over 2 years (2021 to 2023), Janux Therapeutics's accounts receivable has grown at a -100.0% compound annual growth rate (CAGR), from -$7.25M to $0.
What does accounts receivable mean?: Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.